SECURITY AGREEMENTSecurity Agreement • February 26th, 2009 • Synvista Therapeutics, Inc. • Pharmaceutical preparations • New York
SYNVISTA THERAPEUTICS, INC. NOTE PURCHASE AGREEMENTNote Purchase Agreement • February 26th, 2009 • Synvista Therapeutics, Inc. • Pharmaceutical preparations • New York
ContractSenior Secured Promissory Note • February 26th, 2009 • Synvista Therapeutics, Inc. • Pharmaceutical preparations
THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR APPLICABLE STATE SECURITIES LAWS. IT MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS OR EVIDENCE REASONABLY SATISFACTORY TO THE BORROWER THAT SUCH REGISTRATION IS NOT REQUIRED. THE SECURITIES ISSUED UPON SUCH CONVERSION MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT OR APPLICABLE STATE SECURITIES LAWS OR EVIDENCE REASONABLY SATISFACTORY TO THE BORROWER THAT SUCH REGISTRATION IS NOT REQUIRED.
INTELLECTUAL PROPERTY SECURITY AGREEMENTIntellectual Property Security Agreement • February 26th, 2009 • Synvista Therapeutics, Inc. • Pharmaceutical preparations • New York
INTELLECTUAL PROPERTY SECURITY AGREEMENT (this “Agreement”), dated as of February 24, 2009, by and among Synvista Therapeutics, Inc., a Delaware corporation (“Debtor”) and Baker Bros. Advisors, LLC, as Collateral Agent for the Secured Parties (together with its successors and assigns in such capacity, the “Collateral Agent”).
